Bruceoside A TN3543
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Bruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin. It significantly inhibited P-388 lymphocytic leukemic cell RNA and protein synthesis in tissue culture.
CAS nr:
63306-30-9
Purity:
98%
Molecular Weight:
682,7
SMILES:
COC(=O)[C@]12OC[C@@]34C1[C@@H](OC(=O)C=C(C)C)C(=O)O[C@@H]3C[C@H]1[C@H](C)C(=O)C(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)=C[C@]1(C)C4[C@@H](O)[C@@H]2O
Formula:
C32H42O16
Pathway:
Others
Target:
Others
